Profluralin is a dinitroaniline herbicide used to control annual grasses and broadleaf weeds in a variety of crops, including cotton, soybeans, peanuts, and corn. It is a selective herbicide, meaning that it is more toxic to weeds than to crop plants. Profluralin works by inhibiting the formation of microtubules, which are essential for cell division. This disrupts the growth and development of weeds. The synthesis of profluralin involves several steps, including the reaction of 2,6-dinitro-4-trifluoromethyl aniline with 1,3-dichloro-2-propanol. Profluralin has been studied extensively for its effects on plants, animals, and the environment. It is known to be toxic to fish and aquatic invertebrates, and it can accumulate in soil and water. However, its use is regulated in many countries to minimize environmental impacts. Profluralin is still studied because of its potential to provide effective weed control in agricultural systems. Researchers are investigating new formulations and application methods that could reduce the environmental risks associated with its use. Overall, profluralin is an important herbicide that provides significant benefits to agriculture, but its use must be carefully managed to minimize environmental risks.'
ID Source | ID |
---|---|
PubMed CID | 33500 |
CHEMBL ID | 1256764 |
CHEBI ID | 82191 |
SCHEMBL ID | 54045 |
MeSH ID | M0089669 |
Synonym |
---|
benzenamine, n-(cyclopropylmethyl)-2,6-dinitro-n-propyl-4-(trifluoromethyl)- |
p-toluidine, n-(cyclopropylmethyl)-.alpha.,.alpha.,.alpha.-trifluoro-2,6-dinitro-n-propyl- |
profluralin |
cga 10832 |
epa pesticide chemical code 106601 |
hsdb 3923 |
profluraline [iso-french] |
n-cyclopropylmethyl-2,6-dinitro-n-propyl-4-trifluoromethylaniline |
tolban |
ga-10832 |
caswell no. 271bb |
p-toluidine, n-(cyclopropylmethyl)-alpha,alpha,alpha-trifluoro-2,6-dinitro-n-propyl- |
profluralin [ansi:bsi:iso] |
b 4576 |
ai3-62694 |
pregard |
n-cyclopropylmethyl-n-n-propyl-4-trifluoromethyl-2,6-dinitroaniline |
sga 10832 |
brn 2179006 |
einecs 247-656-6 |
p-toluidine, n-(cyclopropylmethyl)-2,6-dinitro-n-propyl-alpha,alpha,alpha-trifluoro- |
profluraline |
n-(cyclopropylmethyl)-alpha,alpha,alpha-trifluoro-2,6-dinitro-n-propyl-p-toluidine |
n-(cyclopropylmethyl)-2,6-dinitro-n-propyl-4-(trifluoromethyl)benzenamine |
er5461 |
n-(cyclopropylmethyl)-2,6-dinitro-n-propyl-4-(trifluoromethyl)aniline |
B-4576 , |
C19065 |
26399-36-0 |
dtxsid2044559 , |
tox21_301566 |
NCGC00255881-01 |
dtxcid0024559 |
cas-26399-36-0 |
CHEMBL1256764 |
chebi:82191 , |
unii-36w2l722ux |
36w2l722ux , |
SCHEMBL54045 |
cga-10832 |
er-5461 |
sga-10832 |
n-cyclopropylmethyl-n-propyl-4-trifluoromethyl-2,6-dinitroaniline |
n-cyclopropylmethyl-.alpha.,.alpha.,.alpha.-trifluoro-2,6-dinitro-n-propyl-p-toluidine |
profluralin [hsdb] |
cg-10832 |
profluralin [mi] |
profluralin [iso] |
er 5461 |
profluralin, pestanal(r), analytical standard |
J-016410 |
n-cyclopropylmethyl-2,6-dinitro -n-propyl-4-(trifluoromethyl)benzenamine |
Q15632821 |
HY-135466 |
CS-0113108 |
AKOS040744784 |
Excerpt | Reference | Relevance |
---|---|---|
" By assessing the type of bonding involved between pesticide and plants or soil, some assessment of the bioavailability of these bound residues to the environment can be made." | ( Incorporation of foreign compound metabolites into plant and soil constituents. Adler, IR; Boka, G; Honeycutt, RC; Secrest, WL; Simoneaux, BJ; Sumner, DD, ) | 0.13 |
Class | Description |
---|---|
C-nitro compound | A nitro compound having the nitro group (-NO2) attached to a carbon atom. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 34.3762 | 0.0010 | 22.6508 | 76.6163 | AID1224839 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 58.5737 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552; AID1159555 |
retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 43.6412 | 0.0008 | 17.5051 | 59.3239 | AID1159531 |
pregnane X nuclear receptor | Homo sapiens (human) | Potency | 19.3312 | 0.0054 | 28.0263 | 1,258.9301 | AID1346982 |
thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 6.3710 | 0.0016 | 28.0151 | 77.1139 | AID1224843; AID1224895 |
thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 68.5896 | 0.0003 | 23.4451 | 159.6830 | AID743065; AID743067 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID522808 | Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay | 2010 | Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4 | Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin. |
AID522805 | Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay | 2010 | Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4 | Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin. |
AID522806 | Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay | 2010 | Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4 | Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin. |
AID522812 | Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay | 2010 | Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4 | Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin. |
AID522816 | Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay | 2010 | Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4 | Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin. |
AID522807 | Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay | 2010 | Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4 | Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin. |
AID522819 | Antimicrobial activity against Cryptosporidium parvum by short-term in vitro culture assay | 2010 | Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4 | Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin. |
AID522815 | Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay | 2010 | Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4 | Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin. |
AID522810 | Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay | 2010 | Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4 | Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin. |
AID522814 | Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay | 2010 | Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4 | Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin. |
AID522813 | Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay | 2010 | Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4 | Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin. |
AID522811 | Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay | 2010 | Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4 | Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin. |
AID522809 | Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay | 2010 | Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4 | Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.04) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |